Golden River Biology intends to repurchase and cancel 2.1 million restricted stocks. Notice to creditors to apply for declaration.

Jinhe Biological Technology Co., Ltd. announced that, due to some incentive targets of the 2023 restricted stock incentive plan not reaching personal performance targets in 2024, and 4 incentive targets not meeting the conditions, the company intends to repurchase and cancel 2.1 million shares of restricted stock that have not been lifted from restriction, resulting in a decrease of 2.1 million yuan in share capital and registered capital. After the repurchase is completed, the company's share capital will decrease from 771,634,398 shares to 769,534,398 shares, and the registered capital will be adjusted accordingly. According to the Company Law, creditors can declare their claims for debt repayment or provide guarantees in person, by letter, or fax from July 23 to September 5, 2025. Late declarations will not affect the validity of the claims.